Literature DB >> 19412191

Recurrent febrile syndromes: what a rheumatologist needs to know.

Hal M Hoffman1, Anna Simon.   

Abstract

Rheumatologists are likely to be asked to evaluate patients with recurrent febrile syndromes, so it is important that they are familiar with the clinical and diagnostic features, pathophysiology and therapeutic options for these rare autoinflammatory disorders. These syndromes are all characterized by recurrent episodes of fever and systemic inflammation; however, some syndromes have unique historical and physical features that can help with making a diagnosis. The primary associated morbidity is systemic amyloidosis, usually with renal involvement. Diagnostic testing is mostly limited to genetic testing. NSAIDs, colchicine and corticosteroids have roles in the treatment of some of these disorders, but biologic drugs that target interleukin-1beta are emerging as consistently effective therapies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412191     DOI: 10.1038/nrrheum.2009.40

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  55 in total

Review 1.  Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes.

Authors:  Anna Simon; Jos W M van der Meer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-24       Impact factor: 3.619

2.  The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review.

Authors:  H A Majeed; M Al-Tarawna; H El-Shanti; B Kamel; F Al-Khalaileh
Journal:  Eur J Pediatr       Date:  2001-12       Impact factor: 3.183

3.  Mevalonic aciduria--an inborn error of cholesterol and nonsterol isoprene biosynthesis.

Authors:  G Hoffmann; K M Gibson; I K Brandt; P I Bader; R S Wappner; L Sweetman
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

4.  Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

Authors: 
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

5.  Prevalence of ischemic heart disease in patients with familial Mediterranean fever.

Authors:  P Langevitz; A Livneh; L Neumann; D Buskila; J Shemer; D Amolsky; M Pras
Journal:  Isr Med Assoc J       Date:  2001-01       Impact factor: 0.892

6.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

Authors:  Hal M Hoffman; Martin L Throne; N J Amar; Mohamed Sebai; Alan J Kivitz; Arthur Kavanaugh; Steven P Weinstein; Pavel Belomestnov; George D Yancopoulos; Neil Stahl; Scott J Mellis
Journal:  Arthritis Rheum       Date:  2008-08

7.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.

Authors:  D Zemer; M Pras; E Sohar; M Modan; S Cabili; J Gafni
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

8.  The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.

Authors:  Ivona Aksentijevich; Christopher D Putnam; Hal M Hoffman; Daniel L Kastner; Elaine F Remmers; James L Mueller; Julie Le; Richard D Kolodner; Zachary Moak; Michael Chuang; Frances Austin; Raphaela Goldbach-Mansky
Journal:  Arthritis Rheum       Date:  2007-04

9.  Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.

Authors:  Jeroen C H van der Hilst; Evelien J Bodar; Karyl S Barron; Joost Frenkel; Joost P H Drenth; Jos W M van der Meer; Anna Simon
Journal:  Medicine (Baltimore)       Date:  2008-11       Impact factor: 1.889

10.  The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.

Authors:  Lorenzo Calligaris; Federico Marchetti; Alberto Tommasini; Alessandro Ventura
Journal:  Eur J Pediatr       Date:  2007-06-23       Impact factor: 3.183

View more
  17 in total

Review 1.  Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes.

Authors:  V U Ozkurede; L Franchi
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  Clinical and genetic characterization of Japanese sporadic cases of periodic Fever, aphthous stomatitis, pharyngitis and adenitis syndrome from a single medical center in Japan.

Authors:  Kazuo Kubota; Hidenori Ohnishi; Takahide Teramoto; Norio Kawamoto; Kimiko Kasahara; Osamu Ohara; Naomi Kondo
Journal:  J Clin Immunol       Date:  2014-04-24       Impact factor: 8.317

3.  Protein inhibitor of acid deoxyribonucleases. Improved purification procedure and properties.

Authors:  P Lesca
Journal:  J Biol Chem       Date:  1976-01-10       Impact factor: 5.157

Review 4.  The NAIP/NLRC4 inflammasomes.

Authors:  Russell E Vance
Journal:  Curr Opin Immunol       Date:  2015-01-24       Impact factor: 7.486

Review 5.  Biologic modulators in allergic and autoinflammatory diseases.

Authors:  Lori Broderick; Louanne M Tourangeau; Arthur Kavanaugh; Stephen I Wasserman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2011-08

6.  Recurrent fever syndromes in patients after recovery from Kawasaki syndrome.

Authors:  Lori Broderick; Adriana H Tremoulet; Jane C Burns; John F Bastian; Hal M Hoffman
Journal:  Pediatrics       Date:  2011-01-10       Impact factor: 7.124

7.  Characterization of NLRP3 variants in Japanese cryopyrin-associated periodic syndrome patients.

Authors:  Hidenori Ohnishi; Takahide Teramoto; Hiroaki Iwata; Zenichiro Kato; Takeshi Kimura; Kazuo Kubota; Ryuta Nishikomori; Hideo Kaneko; Mariko Seishima; Naomi Kondo
Journal:  J Clin Immunol       Date:  2011-12-24       Impact factor: 8.317

8.  In vitro analysis of the functional effects of an NLRP3 G809S variant with the co-existence of MEFV haplotype variants in atypical autoinflammatory syndrome.

Authors:  Kazuo Kubota; Hidenori Ohnishi; Takahide Teramoto; Eiko Matsui; Kana Murase; Hiroyuki Kanoh; Zenichiro Kato; Hideo Kaneko; Mariko Seishima; Naomi Kondo
Journal:  J Clin Immunol       Date:  2012-09-27       Impact factor: 8.317

Review 9.  Therapy of autoinflammatory syndromes.

Authors:  Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 10.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.